 |
|
|
| |
Efficacy and Safety of Elbasvir/Grazoprevir in Women Infected With Hepatitis C Virus Genotypes 1 or 4 and Coadministered Oral Contraceptives or Hormone Replacement Therapy
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Hezode C1; Kwo P2; Sperl J3; Dore G4; Hwang P5; Long J5; Yeh W5; Talwani R5; Robertson M5; Haber B5
1Service d'Hepatologie, Hopital Henri-Mondor, AP-HP, Universite Paris-Est, INSERM U955, Creteil, France; 2Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA; 3Institute for Clinical and
Experimental Medicine, Prague, Czech Republic; 4The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; 5Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
